Morgan Stanley
TNDM icon

Morgan Stanley’s Tandem Diabetes Care TNDM Stock Holding History

Morgan Stanley’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.76M Sell
647,069
-710,473
-52% -$12.4M ﹤0.01% 3700
2026
Q1 		$26M Sell
1,357,542
-722,955
-35% -$15.7M ﹤0.01% 2696
2025
Q4 		$45.7M Buy
2,080,497
+1,342,950
+182% +$24.2M ﹤0.01% 2161
2025
Q3 		$8.95M Sell
737,547
-527,987
-42% -$7.15M ﹤0.01% 3642
2025
Q2 		$23.6M Buy
1,265,534
+334,565
+36% +$6.63M ﹤0.01% 2635
2025
Q1 		$17.8M Buy
930,969
+83,860
+10% +$2.45M ﹤0.01% 2802
2024
Q4 		$30.5M Sell
847,109
-145,602
-15% -$4.93M ﹤0.01% 2323
2024
Q3 		$42.1M Sell
992,711
-26,700
-3% -$1.13M ﹤0.01% 1997
2024
Q2 		$41.1M Sell
1,019,411
-378,734
-27% -$15.8M ﹤0.01% 1941
2024
Q1 		$49.5M Buy
1,398,145
+525,980
+60% +$14.1M ﹤0.01% 1768
2023
Q4 		$25.8M Buy
872,165
+97,522
+13% +$2.02M ﹤0.01% 2417
2023
Q3 		$16.1M Buy
774,643
+371,356
+92% +$10.2M ﹤0.01% 2683
2023
Q2 		$9.9M Sell
403,287
-528,485
-57% -$17M ﹤0.01% 3178
2023
Q1 		$37.8M Buy
931,772
+456,222
+96% +$18.9M ﹤0.01% 1809
2022
Q4 		$21.4M Buy
475,550
+150,957
+47% +$6.83M ﹤0.01% 2271
2022
Q3 		$15.5M Sell
324,593
-206,870
-39% -$11.3M ﹤0.01% 2473
2022
Q2 		$31.5M Buy
531,463
+358,364
+207% +$29.4M ﹤0.01% 1789
2022
Q1 		$20.1M Sell
173,099
-303,197
-64% -$35.4M ﹤0.01% 2111
2021
Q4 		$71.7M Buy
476,296
+166,438
+54% +$22.5M 0.01% 1110
2021
Q3 		$37M Buy
309,858
+27,031
+10% +$2.98M 0.01% 1513
2021
Q2 		$27.5M Sell
282,827
-86,759
-23% -$7.74M ﹤0.01% 1823
2021
Q1 		$32.6M Sell
369,586
-111,371
-23% -$10.4M ﹤0.01% 1507
2020
Q4 		$46M Buy
480,957
+388,910
+423% +$40.1M 0.01% 1160
2020
Q3 		$10.4M Sell
92,047
-212,493
-70% -$22.3M ﹤0.01% 1988
2020
Q2 		$30.1M Buy
304,540
+212,496
+231% +$17M 0.01% 1132
2020
Q1 		$5.92M Sell
92,044
-61,999
-40% -$4.34M ﹤0.01% 2291
2019
Q4 		$9.18M Buy
154,043
+53,492
+53% +$3.3M ﹤0.01% 2516
2019
Q3 		$5.93M Sell
100,551
-63,672
-39% -$4.06M ﹤0.01% 2677
2019
Q2 		$10.6M Buy
164,223
+62,376
+61% +$4.03M ﹤0.01% 2098
2019
Q1 		$6.47M Sell
101,847
-82,489
-45% -$4.33M ﹤0.01% 2459
2018
Q4 		$7M Sell
184,336
-100,856
-35% -$3.56M ﹤0.01% 2509
2018
Q3 		$12.2M Buy
285,192
+182,952
+179% +$6.39M ﹤0.01% 2212
2018
Q2 		$2.25M Buy
102,240
+84,552
+478% +$1.04M ﹤0.01% 3958
2018
Q1 		$88K Buy
17,688
+17,678
+176,780% +$57K ﹤0.01% 5740
2017
Q4 		$0 Hold
10
– – ﹤0.01% 6650
2017
Q3 		$0 Sell
10
-4,778
-100% -$30.2K ﹤0.01% 6614
2017
Q2 		$38K Buy
4,788
+2,321
+94% +$21.5K ﹤0.01% 5928
2017
Q1 		$29K Sell
2,467
-2,987
-55% -$65.3K ﹤0.01% 5978
2016
Q4 		$117K Buy
5,454
+5,044
+1,230% +$194K ﹤0.01% 5521
2016
Q3 		$31K Buy
410
+338
+469% +$24.7K ﹤0.01% 5773
2016
Q2 		$5K Sell
72
-62
-46% -$4.99K ﹤0.01% 6227
2016
Q1 		$11K Sell
134
-1,477
-92% -$129K ﹤0.01% 6109
2015
Q4 		$190K Buy
1,611
+923
+134% +$91.6K ﹤0.01% 5114
2015
Q3 		$60K Sell
688
-2,074
-75% -$241K ﹤0.01% 5656
2015
Q2 		$299K Buy
2,762
+2,260
+450% +$281K ﹤0.01% 5032
2015
Q1 		$63K Sell
502
-138
-22% -$17.9K ﹤0.01% 5707
2014
Q4 		$81K Buy
640
+72
+13% +$9.98K ﹤0.01% 5636
2014
Q3 		$76K Sell
568
-158
-22% -$22.1K ﹤0.01% 5579
2014
Q2 		$118K Sell
726
-308
-30% -$52.4K ﹤0.01% 5419
2014
Q1 		$228K Sell
1,034
-3,230
-76% -$824K ﹤0.01% 5053
2013
Q4 		$1.1M Buy
+4,264
New +$975K ﹤0.01% 3868

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Morgan Stanley's TNDM Position: Q2 2026 in Review

Morgan Stanley reduced its Tandem Diabetes Care (TNDM) stake by 52% in Q2 2026, selling an estimated $12.4M and leaving 647,069 shares worth $9.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3700.

Morgan Stanley first reported a position in TNDM in Q4 2013 and has held it in 51 quarters since. The position peaked at $71.7M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Morgan Stanley held 647,069 shares of Tandem Diabetes Care worth $9.76M as of Q2 2026.
  • Morgan Stanley sold 710,473 Tandem Diabetes Care shares in Q2 2026, an estimated $12.4M.
  • Tandem Diabetes Care made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3700 holding.
  • Morgan Stanley first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 51 quarters since.
  • Morgan Stanley's Tandem Diabetes Care position peaked at $71.7M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.